Specific antibodies, levofloxacin, and modulation of capsule-associated virulence in Streptococcus pneumoniae.
作者信息
Tarragó David, Lara Noelia, Fenoll Asunción, Casal Julio, Giménez María-José, Aguilar Lorenzo, Sevillano David
出版信息
Antimicrob Agents Chemother. 2005 Jul;49(7):3095-6. doi: 10.1128/AAC.49.7.3095-3096.2005.
Abstract
摘要
相似文献
1
Specific antibodies, levofloxacin, and modulation of capsule-associated virulence in Streptococcus pneumoniae.特异性抗体、左氧氟沙星与肺炎链球菌荚膜相关毒力的调节
Antimicrob Agents Chemother. 2005 Jul;49(7):3095-6. doi: 10.1128/AAC.49.7.3095-3096.2005.
2
Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.莫西沙星和左氧氟沙星对肺炎链球菌、金黄色葡萄球菌、肺炎克雷伯菌和大肠杆菌的药效学：体外动力学模型中静脉给药后人体血浆浓度的模拟
J Antimicrob Chemother. 2006 Nov;58(5):960-5. doi: 10.1093/jac/dkl356. Epub 2006 Aug 26.
3
Virulence of Streptococcus pneumoniae may be determined independently of capsular polysaccharide.肺炎链球菌的毒力可能独立于荚膜多糖而被确定。
FEMS Microbiol Lett. 2004 Apr 1;233(1):147-52. doi: 10.1016/j.femsle.2004.02.003.
4
Drastic reduction in the virulence of Streptococcus pneumoniae expressing type 2 capsular polysaccharide but lacking choline residues in the cell wall.表达2型荚膜多糖但细胞壁中缺乏胆碱残基的肺炎链球菌毒力急剧降低。
Mol Microbiol. 2006 Apr;60(1):93-107. doi: 10.1111/j.1365-2958.2006.05082.x.
5
Capsule does not block antibody binding to PspA, a surface virulence protein of Streptococcus pneumoniae.胶囊不会阻碍抗体与肺炎链球菌表面毒力蛋白PspA的结合。
Microb Pathog. 2006 May;40(5):228-33. doi: 10.1016/j.micpath.2006.01.007. Epub 2006 Mar 15.
6
Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis.在大剂量、短疗程左氧氟沙星治疗急性上颌窦炎期间的系列鼻窦抽吸样本。
Diagn Microbiol Infect Dis. 2007 Jan;57(1):105-7. doi: 10.1016/j.diagmicrobio.2006.10.019.
7
Etest compared to broth microdilution: discrepant results when testing macrolides against Streptococcus pneumoniae indicate a need for better clinical and serum level/MIC correlation.Etest法与肉汤微量稀释法的比较：检测大环内酯类药物对肺炎链球菌的药敏时出现的结果差异表明，需要更好地建立临床情况与血清浓度/最低抑菌浓度之间的相关性。
Braz J Infect Dis. 2000 Oct;4(5):268-70.
8
In vivo development of high-level fluoroquinolone resistance in Streptococcus pneumoniae in chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者肺炎链球菌中高水平氟喹诺酮耐药性的体内演变
Clin Infect Dis. 2005 Aug 15;41(4):560-4. doi: 10.1086/432062. Epub 2005 Jul 15.
9
Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.研究小鼠4-1BB与4-1BBL相互作用在肺炎链球菌抗体反应中的重要性的不同方法。
J Leukoc Biol. 2007 Sep;82(3):638-44. doi: 10.1189/jlb.1006628. Epub 2007 Jun 5.
10
Splenic autotransplantation restores IL-17 production and antibody response to Streptococcus pneumoniae in splenectomized mice.脾自体移植可恢复脾切除小鼠对肺炎链球菌的 IL-17 产生和抗体反应。
Transpl Immunol. 2010 Feb;22(3-4):195-7. doi: 10.1016/j.trim.2009.12.002. Epub 2009 Dec 24.
引用本文的文献
1
Seconeolitsine, the Novel Inhibitor of DNA Topoisomerase I, Protects against Invasive Pneumococcal Disease Caused by Fluoroquinolone-Resistant Strains.新乌头碱，一种新型DNA拓扑异构酶I抑制剂，可预防由耐氟喹诺酮菌株引起的侵袭性肺炎球菌疾病。
Antibiotics (Basel). 2021 May 13;10(5):573. doi: 10.3390/antibiotics10050573.
2
Combination of Antibodies and Antibiotics as a Promising Strategy Against Multidrug-Resistant Pathogens of the Respiratory Tract.抗体和抗生素联合使用作为一种有前途的策略，用于对抗呼吸道的多药耐药病原体。
Front Immunol. 2018 Nov 20;9:2700. doi: 10.3389/fimmu.2018.02700. eCollection 2018.
3
Macrolides and β-lactam antibiotics enhance C3b deposition on the surface of multidrug-resistant Streptococcus pneumoniae strains by a LytA autolysin-dependent mechanism.大环内酯类和β-内酰胺类抗生素通过 LytA 自溶素依赖性机制增强多重耐药肺炎链球菌菌株表面的 C3b 沉积。
Antimicrob Agents Chemother. 2012 Nov;56(11):5534-40. doi: 10.1128/AAC.01470-12. Epub 2012 Aug 13.
本文引用的文献
1
Effects of amoxicillin subinhibitory concentrations on the cross-protection developed by pneumococcal antibodies in mouse sepsis caused by an amoxicillin-resistant serotype 6B Streptococcus pneumoniae strain.阿莫西林亚抑菌浓度对由耐阿莫西林的6B型肺炎链球菌菌株引起的小鼠败血症中肺炎球菌抗体产生的交叉保护作用的影响。
Antimicrob Agents Chemother. 2004 Nov;48(11):4144-7. doi: 10.1128/AAC.48.11.4144-4147.2004.
2
Efficacy and pharmacodynamics of gemifloxacin versus levofloxacin in guinea pig pneumococcal pneumonia induced by strains with decreased ciprofloxacin susceptibility.吉米沙星与左氧氟沙星对环丙沙星敏感性降低菌株所致豚鼠肺炎球菌肺炎的疗效及药效学研究
Int J Antimicrob Agents. 2003 Jun;21(6):568-73. doi: 10.1016/s0924-8579(03)00059-1.
3
Pharmacokinetic and pharmacodynamic properties of antimicrobials in the therapy of respiratory tract infections.抗菌药物在呼吸道感染治疗中的药代动力学和药效学特性。
Curr Opin Infect Dis. 2001 Apr;14(2):165-72. doi: 10.1097/00001432-200104000-00010.
4
Effects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of beta-lactams in a mouse sepsis model.抗肺炎链球菌特异性抗体对小鼠脓毒症模型中β-内酰胺类药物药效学参数的影响
Antimicrob Agents Chemother. 2002 May;46(5):1340-4. doi: 10.1128/AAC.46.5.1340-1344.2002.
5
Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies.在流式细胞术检测中使用高度包封的肺炎链球菌菌株来评估血清型特异性抗体的吞噬能力。
Clin Diagn Lab Immunol. 1998 Sep;5(5):703-10. doi: 10.1128/CDLI.5.5.703-710.1998.
6
Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials.左氧氟沙星的药效学：早期临床试验的新范例。
JAMA. 1998 Jan 14;279(2):125-9. doi: 10.1001/jama.279.2.125.
Zotero 插件